Predictors of pathologic complete response after preoperative concurrent chemoradiotherapy of rectal cancer: a single center experience.
- Author:
Euncheol CHOI
1
;
Jin Hee KIM
;
Ok Bae KIM
;
Mi Young KIM
;
Young Ki OH
;
Sung Gyu BAEK
Author Information
- Publication Type:Original Article
- Keywords: Rectum; Rectal neoplasms; Chemoradiotherapy; Stage; Interval
- MeSH: Carcinoembryonic Antigen; Chemoradiotherapy*; Drug Therapy; Female; Hope; Humans; Leucovorin; Multivariate Analysis; Pelvis; Polymerase Chain Reaction; Radiotherapy; Rectal Neoplasms*; Rectum; Retrospective Studies; Risk Factors
- From:Radiation Oncology Journal 2016;34(2):106-112
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: To identify possible predictors of pathologic complete response (pCR) of rectal cancer after preoperative concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: We conducted a retrospective review of 53 patients with rectal cancer who underwent preoperative CCRT followed by radical surgery at a single center between January 2007 and December 2012. The median radiotherapy dose to the pelvis was 54.0 Gy (range, 45.0 to 63.0 Gy). Five-fluorouracil-based chemotherapy was administered via continuous infusion with leucovorin. RESULTS: The pCR rate was 20.8%. The downstaging rate was 66%. In univariate analyses, poor and undifferentiated tumors (p = 0.020) and an interval of ≥7 weeks from finishing CCRT to surgery (p = 0.040) were significantly associated with pCR, while female gender (p = 0.070), initial carcinoembryonic antigen concentration of <5.0 ng/dL (p = 0.100), and clinical stage T2 (p = 0.100) were marginally significant factors. In multivariate analysis, an interval of ≥7 weeks from finishing CCRT to surgery (odds ratio, 0.139; 95% confidence interval, 0.022 to 0.877; p = 0.036) was significantly associated with pCR, while stage T2 (odds ratio, 5.363; 95% confidence interval, 0.963 to 29.877; p = 0.055) was a marginally significant risk factor. CONCLUSION: We suggest that the interval from finishing CCRT to surgery is a predictor of pCR after preoperative CCRT in patients with rectal cancer. Stage T2 cancer may also be an important predictive factor. We hope to perform a robust study by collecting data during treatment to obtain more advanced results.
